A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback